Shire News
Most Popular Shire Story
Shire hikes Adderall price as rumors fly
Amid new speculation that Pfizer might snag Shire in a buyout deal, the specialty pharma is following through on its strategy to switch patients to its newest ADHD med Vyvanse as blockbuster Adderall... Read more...
Latest Headlines
- May 6, 2009
- April 3, 2009
- March 31, 2009
- February 20, 2009
- January 8, 2009
- August 25, 2008
- June 16, 2008
- April 25, 2008
- March 18, 2008
- January 9, 2008
- December 17, 2007
- November 2, 2007
- October 8, 2007
- September 4, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
